MBX Biosciences (MBX) Competitors $14.70 +0.13 (+0.86%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock MBX vs. ANIP, ADPT, DYN, ARQT, VCEL, SRPT, APGE, CDTX, TWST, and BEAMShould you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include ANI Pharmaceuticals (ANIP), Adaptive Biotechnologies (ADPT), Dyne Therapeutics (DYN), Arcutis Biotherapeutics (ARQT), Vericel (VCEL), Sarepta Therapeutics (SRPT), Apogee Therapeutics (APGE), Cidara Therapeutics (CDTX), Twist Bioscience (TWST), and Beam Therapeutics (BEAM). These companies are all part of the "pharmaceutical products" industry. MBX Biosciences vs. Its Competitors ANI Pharmaceuticals Adaptive Biotechnologies Dyne Therapeutics Arcutis Biotherapeutics Vericel Sarepta Therapeutics Apogee Therapeutics Cidara Therapeutics Twist Bioscience Beam Therapeutics ANI Pharmaceuticals (NASDAQ:ANIP) and MBX Biosciences (NYSE:MBX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk. Does the media refer more to ANIP or MBX? In the previous week, ANI Pharmaceuticals had 7 more articles in the media than MBX Biosciences. MarketBeat recorded 11 mentions for ANI Pharmaceuticals and 4 mentions for MBX Biosciences. ANI Pharmaceuticals' average media sentiment score of 1.32 beat MBX Biosciences' score of 0.89 indicating that ANI Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ANI Pharmaceuticals 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MBX Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ANIP or MBX? 76.1% of ANI Pharmaceuticals shares are held by institutional investors. 12.7% of ANI Pharmaceuticals shares are held by company insiders. Comparatively, 52.2% of MBX Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is ANIP or MBX more profitable? MBX Biosciences has a net margin of 0.00% compared to ANI Pharmaceuticals' net margin of -1.37%. ANI Pharmaceuticals' return on equity of 25.03% beat MBX Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets ANI Pharmaceuticals-1.37% 25.03% 8.00% MBX Biosciences N/A N/A N/A Which has higher earnings and valuation, ANIP or MBX? MBX Biosciences has lower revenue, but higher earnings than ANI Pharmaceuticals. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than MBX Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioANI Pharmaceuticals$614.38M3.34-$18.52M-$0.77-122.86MBX BiosciencesN/AN/AN/A-$4.54-3.21 Do analysts rate ANIP or MBX? ANI Pharmaceuticals presently has a consensus target price of $84.75, suggesting a potential downside of 10.42%. MBX Biosciences has a consensus target price of $37.63, suggesting a potential upside of 157.88%. Given MBX Biosciences' higher possible upside, analysts plainly believe MBX Biosciences is more favorable than ANI Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ANI Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryANI Pharmaceuticals beats MBX Biosciences on 9 of the 14 factors compared between the two stocks. Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMBX BiosciencesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$490.17M$833.20M$5.75B$21.15BDividend YieldN/A4.84%6.66%3.50%P/E Ratio-3.211.1382.2029.04Price / SalesN/A26.83531.0548.03Price / CashN/A19.5625.7018.29Price / BookN/A6.5510.475.29Net IncomeN/A-$5.07M$3.28B$997.87M7 Day Performance1.96%0.38%-0.17%-0.63%1 Month Performance6.11%8.39%10.19%6.33%1 Year PerformanceN/A22.17%46.75%13.76% MBX Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMBX Biosciences2.3098 of 5 stars$14.59+0.1%$37.63+157.9%N/A$490.17MN/A-3.2136ANIPANI Pharmaceuticals3.6771 of 5 stars$91.27+1.1%$84.75-7.1%+47.6%$1.98B$614.38M-118.39600News CoveragePositive NewsADPTAdaptive Biotechnologies3.3034 of 5 stars$12.73+0.5%$12.38-2.8%+173.2%$1.94B$178.96M-15.51790Positive NewsDYNDyne Therapeutics3.7854 of 5 stars$13.30+2.3%$34.07+156.1%-70.7%$1.90BN/A-3.47100News CoveragePositive NewsARQTArcutis Biotherapeutics1.9773 of 5 stars$15.83+0.9%$19.80+25.1%+40.8%$1.90B$263.47M-21.14150Positive NewsVCELVericel2.4497 of 5 stars$36.76+2.7%$60.33+64.1%-33.0%$1.85B$237.22M306.36300Positive NewsSRPTSarepta Therapeutics4.7779 of 5 stars$18.16+0.5%$43.50+139.6%-86.6%$1.77B$1.90B-20.841,372Positive NewsAPGEApogee Therapeutics3.211 of 5 stars$37.60+1.8%$99.00+163.3%-26.0%$1.73BN/A-9.1091News CoveragePositive NewsCDTXCidara Therapeutics3.7772 of 5 stars$66.83+4.2%$64.14-4.0%+436.5%$1.69B$1.27M-6.0090News CoveragePositive NewsTWSTTwist Bioscience3.8989 of 5 stars$27.43+0.1%$49.40+80.1%-39.3%$1.66B$312.97M-19.02990News CoveragePositive NewsBEAMBeam Therapeutics2.3694 of 5 stars$16.33-0.7%$48.45+196.7%-38.9%$1.65B$60.27M-3.63510News CoveragePositive NewsGap Up Related Companies and Tools Related Companies ANI Pharmaceuticals Competitors Adaptive Biotechnologies Competitors Dyne Therapeutics Competitors Arcutis Biotherapeutics Competitors Vericel Competitors Sarepta Therapeutics Competitors Apogee Therapeutics Competitors Cidara Therapeutics Competitors Twist Bioscience Competitors Beam Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MBX) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBX Stock Alerts